Sort   by:  
 Page size 
UnknownLoss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study.
Not available
S-EPMC7731769 | biostudies-literature
UnknownThe Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study.
Not available
S-EPMC9563553 | biostudies-literature
UnknownMetabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients.
Not available
S-EPMC4780127 | biostudies-literature
UnknownVitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.
Not available
S-EPMC3718745 | biostudies-literature
UnknownEfficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.
Not available
S-EPMC4393564 | biostudies-literature
UnknownDetermination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas.
Not available
S-EPMC3284423 | biostudies-literature
UnknownThe Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.
Not available
S-EPMC5190017 | biostudies-literature
UnknownThe Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy.
Not available
S-EPMC4259424 | biostudies-literature
UnknownAnalysis of the hippo transducers TAZ and YAP in cervical cancer and its microenvironment.
Not available
S-EPMC4938371 | biostudies-literature
UnknownGenomic Breakpoints' Characterization of a Large CHEK2 Duplication in an Italian Family with Hereditary Breast Cancer.
Not available
S-EPMC9319214 | biostudies-literature
Sort   by:  
 Page size